BIOCRYST PHARMACEUTICALS INC Business Finance Contracts & Agreements

70 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Joinder Agreement to Loan Agreement by BioCryst UK Limited and BioPharma Credit PLC (February 24, 2025)
Joinder Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2025
Amendment Number Two to Credit Agreement among BioCryst Pharmaceuticals, Inc., Guarantors, Lenders, and Athyrium Opportunities III Co-Invest 1 LP
Credit Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2022
Waiver Agreement Relating to BCX9930 Clinical Hold – BioCryst Pharmaceuticals, Inc. and Lenders
Waiver Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2022
BioCryst Pharmaceuticals, Inc. Non-Employee Director Stock Option Agreement
Stock Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2022
BioCryst Pharmaceuticals, Inc. Employee Stock Purchase Plan (Amended and Restated as of April 1, 2021)
Stock Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
Purchase and Sale Agreement between BioCryst Pharmaceuticals, Inc. and RPI 2019 Intermediate Finance Trust (December 7, 2020)
Purchase Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2021
Description of Registered Securities of BioCryst Pharmaceuticals, Inc.
Stock Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
Third Amendment to Second Amended and Restated Credit and Security Agreement among BioCryst Pharmaceuticals, Inc., MDCP, LLC, and MidCap Financial Trust
Credit Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2020
BioCryst Pharmaceuticals, Inc. Pre-Funded Warrant to Purchase Common Stock (Baker Brothers Life Sciences, L.P./667, L.P.)
Warrant Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2020
Underwriting Agreement between BioCryst Pharmaceuticals, Inc. and J.P. Morgan Securities LLC, Piper Sandler & Co. (May 27, 2020)
Underwriting Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2020
BioCryst Pharmaceuticals, Inc. Employee Stock Purchase Plan (Amended and Restated as of March 19, 2020)
Stock Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2020
BioCryst Pharmaceuticals, Inc. Form of Pre-Funded Warrant to Purchase Common Stock (Baker Brothers Life Sciences, L.P./667, L.P.)
Warrant Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2019
Securities Purchase Agreement between BioCryst Pharmaceuticals, Inc. and 667, L.P. & Baker Brothers Life Sciences, L.P.
Purchase Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2019
Underwriting Agreement between BioCryst Pharmaceuticals, Inc. and J.P. Morgan Securities LLC (November 13, 2019)
Underwriting Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2019
Second Amendment to Second Amended and Restated Credit and Security Agreement by and among BioCryst Pharmaceuticals, Inc., MDCP, LLC, and MidCap Financial Trust
Credit Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2019
First Amendment to Second Amended and Restated Credit and Security Agreement by and among BioCryst Pharmaceuticals, Inc., MDCP, LLC, and MidCap Financial Trust
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2019
Second Amended and Restated Credit and Security Agreement among MidCap Financial Trust, Lenders, and BioCryst Pharmaceuticals, Inc.
Credit Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
MD
2019
Amended and Restated Credit and Security Agreement among MidCap Financial Trust, BioCryst Pharmaceuticals, Inc., MDCP, LLC, and Lenders (July 20, 2018)
Credit Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
MD
2018
Modification No. 22 to Contract No. IIllSN272201300017C Increasing Estimated Cost for Option 10
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2018
Amendment No. 0010 to Contract HHSO100201500007C between ASPR-BARDA and BioCryst Pharmaceuticals, Inc.
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2018
Underwriting Agreement between BioCryst Pharmaceuticals, Inc. and J.P. Morgan Securities LLC, Jefferies LLC (August 1, 2018)
Underwriting Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2018
Underwriting Agreement between BioCryst Pharmaceuticals, Inc. and J.P. Morgan Securities LLC, Barclays Capital Inc., and Other Underwriters (September 12, 2017)
Underwriting Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2017
BioCryst Pharmaceuticals, Inc. Registration Rights Agreement with Investors (March 15, 2017)
Registration Rights Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2017
Underwriting Agreement between BioCryst Pharmaceuticals, Inc. and J.P. Morgan Securities LLC (March 9, 2017)
Underwriting Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2017
Credit and Security Agreement among MidCap Financial Trust, Lenders, and BioCryst Pharmaceuticals, Inc.
Credit Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
MD
2016
Amendment No. 19 to Contract HHSN272201300017C between National Institutes of Health and BioCryst Pharmaceuticals, Inc.
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2016
Novation Agreement among AECOM, BioCryst, Mundipharma, Callaghan Innovation Research, and Victoria Link Limited
Assignment Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2015
Novation Agreement among Albert Einstein College of Medicine, BioCryst Pharmaceuticals, Callaghan Innovation Research, and Victoria Link Limited
Assignment Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2015
BioCryst Pharmaceuticals, Inc. Standard Stock Option Agreement with Employee or Consultant
Stock Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2015
Contract Modification Agreement between ASPR-BARDA and BioCryst Pharmaceuticals, Inc. (Extension of Expiration Date)
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2014
Underwriting Agreement between BioCryst Pharmaceuticals, Inc. and J.P. Morgan Securities LLC (May 28, 2014)
Underwriting Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2014
BioCryst Pharmaceuticals, Inc. Employee Stock Purchase Plan (Amended and Restated March 8, 2014)
Equity Distribution Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2014
Amendment to Contract HHSO100200700032C Between ASPR-BARDA and BioCryst Pharmaceuticals, Inc.
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2014
Amendment No. 0018 to Contract HHSO100200700032C Between ASPR-BARDA and BioCryst Pharmaceuticals, Inc.
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2014
Amendment No. 2 to Contract HHSN272201300017C Between National Institute of Allergy and Infectious Diseases and BioCryst Pharmaceuticals, Inc.
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2014
Amendment No. 1 to Contract HHSN272201300017C between National Institutes of Health and BioCryst Pharmaceuticals, Inc.
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2014
Amendment No. 013 to Contract HHS0100200700032C Between BARDA and BioCryst Pharmaceuticals, Inc.
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2014
Amendment to Contract HHSO100200700032C between ASPR-BARDA and BioCryst Pharmaceuticals, Inc. (Extension of Expiration Date)
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2014
Underwriting Agreement between BioCryst Pharmaceuticals, Inc. and Underwriters for 4,000,000 Shares of Common Stock (July 31, 2013)
Underwriting Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2013
Amendment No. 14 to Contract HHS0100200700032C Between HHS and BioCryst Pharmaceuticals, Inc.
Modification Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2013